The reactome enrichment scatter plot (Figure 4E) highlighted pathways, such as constitutive signaling by aberrant PI3K in cancer and PI3K/AKT signaling in cancer, which are relevant to Esc’s anti-CRC effects. The gene discussed is AKT1; the disease is cancer.